Madrigal appoints Rita Thakkar as SVP and Chief Accounting Officer, effective Jan 12, 2026

MADRIGAL PHARMACEUTICALS, INC.

Rita Thakkar joins as principal accounting officer; Mardi Dier remains CFO and principal financial officer.
Thakkar previously SVP Global Business Operations at Bristol Myers Squibb and Chief Audit Officer at BMS and Celgene.
Annual base salary of $450,000 with target bonus of 40% of salary; initial equity grant valued at $1,932,000.
Equity award composed of 70% time-based RSUs (4-year vest) and 30% stock options (graded vest over 4 years).
Severance agreement provides 12 months salary and bonus upon qualifying separation, with enhanced benefits on change of control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.